StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

MYGN — Myriad Genetics, Inc.

EXPENSIVE (MOS -60.7%) · Quality 41/100

Price
3.89
Intrinsic value
2.42
Margin of safety
-60.7%
Implied growth (reverse DCF)
+6.4%
model assumes +0.0%
Value Score
8.5
Quality
41
Psychology
24.6
Discovery
31.2
price/volume attention only
Moat score
38
erosion: none

Value Score: bottom 11% of Russell 3000 · Quality: bottom 26%

Open the interactive Deep Dive for MYGN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/MYGN - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is MYGN undervalued?

As of 2026-09-19, MYGN trades at 3.89 against a computed intrinsic value of 2.42 (-60.7% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Myriad Genetics, Inc.'s Value Score?

Myriad Genetics, Inc.'s Value Score is 8.5 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.